Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2550]

Ten year data confirms the early and long-term benefits of anastrozole over tamoxifen

Ten year data confirms the early and long-term benefits of anastrozole over tamoxifen

Reduction in lung cancer risk among people with higher levels of vitamin B6 and methionine

Reduction in lung cancer risk among people with higher levels of vitamin B6 and methionine

Cardiologists discover cancer risks in group of blood pressure medications

Cardiologists discover cancer risks in group of blood pressure medications

EHA press briefing: Lymphoma and Leukaemia

EHA press briefing: Lymphoma and Leukaemia

ASCO 2010: Bevacizumab prolongs progression-free survival for advanced ovarian cancer

ASCO 2010: Bevacizumab prolongs progression-free survival for advanced ovarian cancer

ASCO 2010: No prevention benefit of selenium for secondary tumours in non-small cell lung cancer

ASCO 2010: No prevention benefit of selenium for secondary tumours in non-small cell lung cancer

ASCO 2010: Novel ALK inhibitor shows high response rate in patients with advanced NSCLC with specific ALK gene alteration

ASCO 2010: Novel ALK inhibitor shows high response rate in patients with advanced NSCLC with specific ALK gene...

ASCO 2010: Paclitaxel and carboplatin combo increases survival in advanced lung cancer in elderly

ASCO 2010: Paclitaxel and carboplatin combo increases survival in advanced lung cancer in elderly

ASCO 2010: Targeted intraoperative radiotherapy is as good as whole breast radiotherapy at reducing breast cancer recurrence

ASCO 2010: Targeted intraoperative radiotherapy is as good as whole breast radiotherapy at reducing breast cancer...

Addition of Vandetanib improves progression-free survival in patients with the most common form of lung cancer

Addition of Vandetanib improves progression-free survival in patients with the most common form of lung cancer

More from ecancer